Femme et Homme
- | Pays :
- United States
- | Organes : -
- | Spécialités : -
Extrait
This is a randomized, double-blind, placebo-controlled study of single and multiple ascending dosage levels of AZD6423 in healthy volunteers. The study includes an up to 28-day screening period, an in-house period during which AZD6423 or placebo will be administered IV, and a 4- to 10-day follow-up period after discharge.
Critère d'inclusion
- Healthy Volunteers